phosphonoacetic acid has been researched along with Hepatitis B in 8 studies
Phosphonoacetic Acid: A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent.
phosphonoacetic acid : A member of the class of phosphonic acids that is phosphonic acid in which the hydrogen attached to the phosphorous is replaced by a carboxymethyl group.
Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Foscarnet has been shown to inhibit the proliferation of human T and B lymphocytes in vitro." | 1.28 | Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response? ( Hansson, BG; Nordenfelt, E; Riesbeck, K; Weiland, O, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (87.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Galasso, GJ | 1 |
| Lin, HJ | 1 |
| Wu, PC | 1 |
| Lai, CL | 1 |
| Chak, W | 1 |
| Hansson, BG | 2 |
| Riesbeck, K | 1 |
| Nordenfelt, E | 2 |
| Weiland, O | 2 |
| Bain, VG | 1 |
| Daniels, HM | 1 |
| Chanas, A | 1 |
| Alexander, GJ | 1 |
| Williams, R | 1 |
| Price, JS | 1 |
| France, AJ | 1 |
| Moaven, LD | 1 |
| Welsby, PD | 1 |
| Sherker, AH | 1 |
| Hirota, K | 1 |
| Omata, M | 1 |
| Okuda, K | 1 |
| Tsiquaye, KN | 1 |
| Collins, P | 1 |
| Zuckerman, AJ | 1 |
| Hedin, G | 1 |
| Ljunggren, K | 1 |
| Strömberg, A | 1 |
| Oberg, B | 1 |
1 review available for phosphonoacetic acid and Hepatitis B
| Article | Year |
|---|---|
Antiviral agents: the road from scepticism to efficacy.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Clinical Trials as Topic; Guanine; Hepat | 1981 |
1 trial available for phosphonoacetic acid and Hepatitis B
| Article | Year |
|---|---|
Antiviral agents: the road from scepticism to efficacy.
Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Clinical Trials as Topic; Guanine; Hepat | 1981 |
7 other studies available for phosphonoacetic acid and Hepatitis B
| Article | Year |
|---|---|
Micromethod for phosphonoformate inhibition assay of hepatitis B viral DNA polymerase.
Topics: Deoxycytosine Nucleotides; DNA-Directed DNA Polymerase; Foscarnet; Hepatitis B; Hepatitis B virus; H | 1984 |
Successful treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection explained by inhibitory effect on the immune response?
Topics: Antiviral Agents; B-Lymphocytes; Cell Line; Cells, Cultured; DNA; Foscarnet; Hepatitis B; Hepatitis | 1991 |
Foscarnet therapy in chronic hepatitis B virus E antigen carriers.
Topics: Adult; Antiviral Agents; Carrier State; DNA, Viral; Foscarnet; Hepatitis B; Hepatitis B Surface Anti | 1989 |
Foscarnet in fulminant hepatitis B.
Topics: Adolescent; Antiviral Agents; Foscarnet; Hepatic Encephalopathy; Hepatitis B; Humans; Organophosphor | 1986 |
Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
Topics: Animals; Antiviral Agents; DNA, Viral; Dose-Response Relationship, Drug; Ducks; Enterovirus Infectio | 1986 |
Screening of antiviral drugs for treatment of hepatitis B.
Topics: Acyclovir; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Ducks; Foscarnet; Hepatitis B; H | 1986 |
Treatment of fulminant hepatitis B and fulminant hepatitis B and D coinfection with foscarnet.
Topics: Acute Disease; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Hepatitis B; Hepatitis D; Hum | 1987 |